• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌中上皮-间充质转化基因的生存和富集分析。

Survival and Enrichment Analysis of Epithelial-Mesenchymal Transition Genes in Bladder Urothelial Carcinoma.

机构信息

Albert Einstein College of Medicine, New York, NY 10461, USA.

Professor of Pathology, University of Illinois at Chicago College of Medicine, Chicago, IL 60607, USA.

出版信息

Genes (Basel). 2023 Sep 30;14(10):1899. doi: 10.3390/genes14101899.

DOI:10.3390/genes14101899
PMID:37895248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10606556/
Abstract

The escalating prevalence of bladder cancer, particularly urothelial carcinoma, necessitates innovative approaches for prognosis and therapy. This study delves into the significance of genes related to epithelial-mesenchymal transition (EMT), a process inherently linked to carcinogenesis and comparatively better studied in other cancers. We examined 1184 EMT-related gene expression levels in bladder urothelial cancer cases through the TCGA dataset. Genes shown to be differentially expressed in relation to survival underwent further network and enrichment analysis to uncover how they might shape disease outcomes. Our in silico analysis revealed a subset of 32 genes, including those significantly represented in biological pathways such as VEGF signaling and bacterium response. In addition, these genes interact with genes involved in the JAK-STAT signaling pathway. Additionally, some of those 32 genes have been linked to immunomodulators such as chemokines CCL15 and CCL18, as well as to various immune cell infiltrates. Our findings highlight the prognostic utility of various EMT-related genes and identify possible modulators of their effect on survival, allowing for further targeted wet lab research and possible therapeutic intervention.

摘要

膀胱癌(尤其是尿路上皮癌)的患病率不断上升,这就需要创新的方法来进行预后和治疗。本研究探讨了与上皮-间充质转化(EMT)相关的基因的意义,EMT 是一个与癌症发生密切相关的过程,在其他癌症中研究得更为深入。我们通过 TCGA 数据集研究了 1184 例膀胱尿路上皮癌病例中与 EMT 相关的基因表达水平。对与生存相关的差异表达基因进行了进一步的网络和富集分析,以揭示它们如何影响疾病结局。我们的计算机分析揭示了 32 个基因亚组,其中包括在 VEGF 信号转导和细菌反应等生物学途径中显著表达的基因。此外,这些基因与参与 JAK-STAT 信号通路的基因相互作用。此外,其中一些 32 个基因与免疫调节剂(如趋化因子 CCL15 和 CCL18)以及各种免疫细胞浸润有关。我们的研究结果突出了各种 EMT 相关基因的预后效用,并确定了它们对生存影响的可能调节剂,这为进一步的靶向湿实验室研究和可能的治疗干预提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/3d387f0bfc91/genes-14-01899-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/b430ed3b1cdb/genes-14-01899-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/44d3cbac7770/genes-14-01899-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/8c40a6930e23/genes-14-01899-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/5f6b343c8396/genes-14-01899-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/fa33e9c438d6/genes-14-01899-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/c1eac8b769de/genes-14-01899-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/57f04e2e11bb/genes-14-01899-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/3d387f0bfc91/genes-14-01899-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/b430ed3b1cdb/genes-14-01899-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/44d3cbac7770/genes-14-01899-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/8c40a6930e23/genes-14-01899-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/5f6b343c8396/genes-14-01899-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/fa33e9c438d6/genes-14-01899-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/c1eac8b769de/genes-14-01899-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/57f04e2e11bb/genes-14-01899-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6819/10606556/3d387f0bfc91/genes-14-01899-g008.jpg

相似文献

1
Survival and Enrichment Analysis of Epithelial-Mesenchymal Transition Genes in Bladder Urothelial Carcinoma.膀胱癌中上皮-间充质转化基因的生存和富集分析。
Genes (Basel). 2023 Sep 30;14(10):1899. doi: 10.3390/genes14101899.
2
Bladder Tumor Subtype Commitment Occurs in Carcinoma Driven by Key Signaling Pathways Including ECM Remodeling.膀胱癌亚型的形成与关键信号通路有关,包括细胞外基质重塑,这些通路驱动了癌的发生。
Cancer Res. 2021 Mar 15;81(6):1552-1566. doi: 10.1158/0008-5472.CAN-20-2336. Epub 2021 Jan 20.
3
PXDNL activates the motility of urothelial bladder carcinoma cells through the Wnt/β-catenin pathway and has a prognostic value.PXDNL 通过 Wnt/β-catenin 通路激活尿路上皮膀胱癌细胞的迁移能力,并且具有预后价值。
Life Sci. 2023 Jan 1;312:121270. doi: 10.1016/j.lfs.2022.121270. Epub 2022 Dec 6.
4
Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma.与膀胱尿路上皮癌上皮-间质转化和能量代谢相关基因的预后意义及免疫浸润分析。
Aging (Albany NY). 2023 Nov 24;15(22):13312-13328. doi: 10.18632/aging.205242.
5
PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition.PRMT5 环状 RNA 通过海绵吸附 miR-30c 促进膀胱癌尿路上皮癌转移诱导上皮-间充质转化。
Clin Cancer Res. 2018 Dec 15;24(24):6319-6330. doi: 10.1158/1078-0432.CCR-18-1270. Epub 2018 Oct 10.
6
Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.尿路上皮癌干细胞与上皮可塑性:膀胱癌的当前概念及治疗意义
Cancer Metastasis Rev. 2015 Dec;34(4):691-701. doi: 10.1007/s10555-015-9589-6.
7
Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.肿瘤干性评分用于评估上皮间质转化(EMT)和癌症干细胞(CSCs)特征,并预测膀胱癌的预后和免疫治疗反应。
Stem Cell Res Ther. 2023 Feb 1;14(1):15. doi: 10.1186/s13287-023-03239-1.
8
Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.膀胱尿路上皮癌患者的上皮-间质转化及其与临床病理特征的相关性
Clin Genitourin Cancer. 2017 Apr;15(2):e187-e197. doi: 10.1016/j.clgc.2016.07.021. Epub 2016 Aug 9.
9
Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.Krüppel样因子4是膀胱尿路上皮癌一种新的预后预测指标,并且它调节TWIST1介导的上皮-间质转化。
Urol Oncol. 2016 Nov;34(11):485.e15-485.e24. doi: 10.1016/j.urolonc.2016.07.002. Epub 2016 Aug 9.
10
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.TEAD4 在膀胱癌中作为预后生物标志物,通过 PI3K/AKT 通路触发 EMT。
J Exp Clin Cancer Res. 2022 May 17;41(1):175. doi: 10.1186/s13046-022-02377-3.

本文引用的文献

1
miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers.miRNA/上皮-间充质轴(EMT 轴)作为癌症进展和转移的关键参与者:以胃癌和膀胱癌为例。
Cell Signal. 2023 Dec;112:110881. doi: 10.1016/j.cellsig.2023.110881. Epub 2023 Sep 4.
2
TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling.TBX3通过人乳头瘤病毒E6和E7信号通路促进宫颈癌的增殖和迁移。
Mol Cancer Res. 2023 Apr 1;21(4):345-358. doi: 10.1158/1541-7786.MCR-22-0598.
3
CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.
CSF1R 抑制剂是癌症治疗中新兴的免疫治疗药物。
Eur J Med Chem. 2023 Jan 5;245(Pt 1):114884. doi: 10.1016/j.ejmech.2022.114884. Epub 2022 Oct 29.
4
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.膀胱癌倡导网络的协作研究,用于转移性尿路上皮癌的基因组分析。
Nat Commun. 2022 Nov 4;13(1):6658. doi: 10.1038/s41467-022-33980-9.
5
CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer.CEMIP,一种促进结直肠癌及其他类型癌症进展和转移的有前景的生物标志物。
Cancers (Basel). 2022 Oct 18;14(20):5093. doi: 10.3390/cancers14205093.
6
Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from "first contact" interactions in the tumor microenvironment.从肿瘤微环境中的“初次接触”相互作用中鉴定新型早期胰腺癌生物标志物 KIF5B 和 SFRP2。
J Exp Clin Cancer Res. 2022 Aug 24;41(1):258. doi: 10.1186/s13046-022-02425-y.
7
RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis.RUNX2 招募 NuRD(MTA1)/CRL4B 复合物促进乳腺癌的进展和骨转移。
Cell Death Differ. 2022 Nov;29(11):2203-2217. doi: 10.1038/s41418-022-01010-2. Epub 2022 May 9.
8
DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.基于 DNA 甲基化的结直肠癌诊断、预后和预测生物标志物。
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188722. doi: 10.1016/j.bbcan.2022.188722. Epub 2022 Mar 17.
9
PTPN6-EGFR Protein Complex: A Novel Target for Colon Cancer Metastasis.蛋白酪氨酸磷酸酶非受体型6-表皮生长因子受体蛋白复合物:结肠癌转移的新靶点
J Oncol. 2022 Feb 11;2022:7391069. doi: 10.1155/2022/7391069. eCollection 2022.
10
Harnessing Antitumor CD4 T Cells for Cancer Immunotherapy.利用抗肿瘤CD4 T细胞进行癌症免疫治疗。
Cancers (Basel). 2022 Jan 5;14(1):260. doi: 10.3390/cancers14010260.